Metagenomics Sequencing Market worth USD 2564.01 million by 2027

global metagenomics sequencing market size is expected to grow from USD 974.3 million in 2020 to USD 2564.01 million by 2027, at a CAGR of 17.5% during the forecast period

The Market Statsville Group (MSGpublishes the new report on the "Metagenomics Sequencing Market by Product Services (Reagents Consumables, Instruments, and Services (Analysis Data Interpretation Solutions and Metagenomic Sequencing Services)), by Technology (16S rRNA Sequencing, Whole Genome Sequencing De Novo Assembly, Shotgun Metagenomics Sequencing, and Metatranscriptomics), by Application (Ecological Environmental Metagenomics, Clinical Diagnostics, Drug Discovery, Biofuel, and Industrial Applications), by Region – Global Share and Forecast to 2027"The global metagenomics sequencing market size is expected to grow from USD 974.3 million in 2020 to USD 2564.01 million by 2027, at a CAGR of 17.5during the forecast periodMetagenomics plays a vital role in the genomic field; besides applying metagenomics in biocatalysts from nature, it also has found applications in fields as diverse as bioremediation, ecological environmental metagenomics, clinical diagnostic, drug discovery, and industrial applicationClinical diagnostic metagenomics enables pathogen detection by unbiased next-generation sequencingRecently, metagenomic sequencing and bioinformatics technology have increased the adoption of precision diagnostic tests based on metagenomics sequencingIn addition, the DNA extracted from the desired organism then purified, cloned, and expressed in a heterologous host such as function-based screenings can be useful for discovering novel proteins such as antibioticsHence, such various applications supplement the market growth.

Get Full PDF Sample Copy of Report: 

Global Metagenomics Sequencing Market Segmentation

The overall metagenomics sequencing market has been segmented into product services, technology, application, and region.

By Product Services Outlook (Sales, USD Million, 2017-2027)

  • Reagents Consumables
  • Instruments
  • Services
    • Analysis Data Interpretation Solutions
    • Metagenomic Sequencing Services

By Technology Outlook (Sales, USD Million, 2017-2027)

  • Shotgun Metagenomics Sequencing
  • 16S rRNA Sequencing
  • Whole Genome Sequencing De Novo Assembly
  • Metatranscriptomics

By Application Outlook (Sales, USD Million, 2017-2027)

  • Drug Discovery
  • Ecological Environmental Metagenomics
  • Clinical Diagnostics
  • Biofuel
  • Industrial Applications

By Region Outlook (Sales, USD Million, 2017-2027)

  • North America (US, Canada, Mexico)
  • South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
  • Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
  • Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia New Zealand, Rest of Asia Pacific)
  • The Middle East Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)

Make an Enquire before Purchase @: 

Shotgun metagenomic sequencing, by technology, is estimated to hold the largest market share during the forecast period

By technology, the global metagenomic sequencing market is categorized into shotgun metagenomics sequencing, 16S rRNA sequencing, whole-genome sequencing de novo assembly, and metatranscriptomicsIn 2020, shotgun metagenomic sequencing accounted for the largest market, with a 30.2market shareThe shotgun metagenomic sequencing segment is expected to showcase lucrative market growth during the forecast periodFactors such as advantages offered by shotgun sequencing are better than other technologies, growth in the adoption and preference toward shotgun metagenomic sequencing among researchers healthcare professionals, and the surge in the number of metagenomic sequencing-based research activities are anticipated to propel the growth of the industry.

The rise in preference toward adopting shotguns due to better advantages is anticipated to help the global metagenomics sequencing market gain tractionSince the past few years, shotgun metagenomic sequencing has increased due to the application where all the genomes in DNA can be read with the help of shotgun metagenomic sequencingThere has been an increase in the number of product launches accomplished by players with shotgun metagenomic sequencing, which is expected to help the market generate higher revenue from this segment.

North America accounts for the largest market share in the metagenomic sequencing market 2020

The global metagenomics sequencing market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East AfricaIn 2020, North America accounted for the highest market share of 42.3in the global metagenomics sequencing market and was anticipated to maintain its dominance throughout the forecast periodStronghold on Deoxyribonucleic Acid (DNAsequencing technologies due to the continuous improvement, availability, and accessibility of DNA sequencing in North AmericaSeveral global manufacturers of DNA sequencing, platforms, equipment, and technologies are highly active in North America, especially in the U.SFor instance, key market players, such as Illumina, Inc., Thermo Fisher Scientific Inc., and others, have their corporate presence in this regionHence, most DNA sequencing products and platforms are first launched in the U.Sand then distributed to other world regions.

Don't miss out on business opportunities in Metagenomics Sequencing Market. Speak to our research analyst and gain crucial market insights to grow your business.

 The key market players strive to introduce affordable DNA sequencing technologies in North AmericaThis has provided momentum to the global metagenomics market in this region, enabling further investigation of microbial ecologyMoreover, the North American market has witnessed tremendous developments regarding the utilization of metagenomics products and technologies in biotechnology, which are expected to make way for new avenues and provide numerous growth opportunities for the expansion of the market.

This research report covers an analysis of the major firms' development and marketing tactics and a study of their product portfolios and winning methods in the plastic bottles and containers industryIllumina, Inc., Macrogen Inc., BGI Genomics Co., Ltd., Eurofins Genomics, Oxford Nanopore Technologies Ltd, QIAGEN N.V., Swift Biosciences Inc., Pacific Biosciences of California, Inc., Thermo Fisher Scientific Inc., and PerkinElmer Incare among the prominent businesses representedEach firm pursues its own business plan to gain a major market share.

Browse complete report:

Market Statsville Group

215 Blog posts